First death confirmation from Guilan-Barry syndrome: Understanding treatment options
The first suspected death related to GBS was reported from Solapur in Maharashtra.

The Center on Monday deployed a seven-member team of experts in Maharashtra to assist the state in the Guilan-Barri syndrome (GBS) increasing cases and management.
Recent outbreaks have raised health concerns, especially after the first death confirmation of rare neurological disorders.
So far 101 cases have been registered in Maharashtra, health officials have seen an increase in patients with intensive care. The first suspected death related to GBS was reported from Solapur in Maharashtra.
What is Guilan-Barry syndrome?
Guilan-Berry Syndrome (GBS) is a rare neurological condition in which the body’s immune system attacks nerves, causing weakness, numbness, or even paralysis.
GBS is not only rare, but its exact reasons are also unknown. According to the Mayo Clinic, most people with Guilan-Berry syndrome have experienced the symptoms of infection at least six weeks before the GBS symptoms appear.
These infections include any respiratory disease or gastrointestinal infection.
Symptoms of GBS include weakness, which is first experienced within the legs, and then can grow from the body to the feet, arms, face and breathing muscles.
What is the treatment of Guilan-Barry syndrome?
Interior immunoglobulin (IVIG) therapy or plasma exchanges are two therapy designed to reduce the immune system attack on the nervous system. However, the process of recovering from rare neurological disease may be prolonged.
For those who experience muscle weakness or sudden onset of tingling, it is necessary to seek immediate medical help to avoid possible complications.
Currently, no specific vaccine has been created to prevent Guilan-Berry syndrome (GBS).
Health officers are actively monitoring the situation and emphasizing the importance of maintaining proper hygiene and obtaining timely medical care.
Although GBS is not contagious and usually does not cause outbreak, recent increase in cases highlights the need for public awareness and preventive strategies.
While GBS is prevalent in both pediatric and youth age group, experts say that it will not cause epidemic or epidemic.